Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons

Cell Metabolism

Volumn 5, Issue 4, 2007, Pages 279-291

  Beigneux, Anne P ^a   Davies, Brandon S J ^a   Gin, Peter ^a   Weinstein, Michael M ^a   Farber, Emily ^a   Qiao, Xin ^a   Peale, Franklin ^b   Bunting, Stuart ^b   Walzem, Rosemary L ^c   Wong, Jinny S ^d   Blaner, William S ^e   Ding, Zhi Ming ^f   Melford, Kristan ^g   Wongsiriroj, Nuttaporn ^e   Shu, Xiao ^g   de Sauvage, Fred ^b   Ryan, Robert O ^g   Fong, Loren G ^a   Bensadoun, André ^h   Young, Stephen G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f LEXICON PHARMACEUTICALS INC   (United States)

^g CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^h Department of Obstetrics Gynecology   (United States)

Author keywords

DEVBIO; HUMDISEASE

Indexed keywords

CHOLESTEROL; CHYLOMICRON; GLYCOSYLPHOSPHATIDYLINOSITOL; HIGH DENSITY LIPOPROTEIN RECEPTOR; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CAPILLARY ENDOTHELIUM; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART; HYDROLYSIS; LIPOLYSIS; LIQUID CHROMATOGRAPHY; LOW FAT DIET; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; CHO CELLS; CHYLOMICRONS; CRICETINAE; CRICETULUS; EATING; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; LIPOLYSIS; LIPOPROTEIN LIPASE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; RABBITS; RECEPTORS, LIPOPROTEIN; TRANSFECTION;

MUS;

EID: 33947573537     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.02.002     Document Type: Article

References (46)

1. Beckstead J.A., Oda M.N., Martin D.D.O., Forte T.M., Bielicki J.K., Berger T., Luty R., Kay C.M., and Ryan R.O. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 42 (2003) 9416-9423
2. Bengtsson G., and Olivecrona T. Apolipoprotein CII enhances hydrolysis of monoglycerides by lipoprotein lipase, but the effect is abolished by fatty acids. FEBS Lett. 106 (1979) 345-348
3. Bensadoun A., Hsu J., and Hughes B. Large-scale lipoprotein lipase purification from adipose tissue. Methods Mol. Biol. 109 (1999) 145-150
4. Blaner W.S., Obunike J.C., Kurlandsky S.B., al-Haideri M., Piantedosi R., Deckelbaum R.J., and Goldberg I.J. Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J. Biol. Chem. 269 (1994) 16559-16565
5. Breckenridge W.C., Little J.A., Steiner G., Chow A., and Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl. J. Med. 298 (1978) 1265-1273
6. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
7. Brunzell J.D., and Deeb S.S. Familial lipoprotein lipase deficiency, Apo C-II deficiency, and hepatic lipase deficiency. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 2789-2816
8. Burger H., Kovacs A., Weiser B., Grimson R., Nachman S., Tropper P., van Bennekum A.M., Elie M.C., and Blaner W.S. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14 (1997) 321-326
9. Calandra S., Oliva C.P., Tarugi P., and Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr. Opin. Lipidol. 17 (2006) 122-127
10. Cardin A.D., Barnhart R.L., Witt K.R., and Jackson R.L. Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100. Thromb. Res. 34 (1984) 541-550
11. Cardin A.D., Hirose N., Blankenship D.T., Jackson R.L., and Harmony J.A.K. Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem. Biophys. Res. Commun. 134 (1986) 783-789
12. Cardin A.D., Jackson R.L., Sparrow D.A., and Sparrow J.T. Interaction of glycosaminoglycans with lipoproteins. Ann. N Y Acad. Sci. 556 (1989) 186-193
13. Cheng C.-F., Oosta G.M., Bensadoun A., and Rosenberg R.D. Binding of lipoprotein lipase to endothelial cells in culture. J. Biol. Chem. 256 (1981) 12893-12898
14. Cisar L.A., Hoogewerf A.J., Cupp M., Rapport C.A., and Bensadoun A. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. J. Biol. Chem. 264 (1989) 1767-1774
15. Cole T., Kitchens R., Daugherty A., and Schonfeld G. An improved method for separation of triglyceride-rich lipoproteins by FPLC. FPLC BioCommuniqué 4 (1988) 4-6
16. Cunningham O., Andolfo A., Santovito M.L., Iuzzolino L., Blasi F., and Sidenius N. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22 (2003) 5994-6003
17. Esko J.D. Genetic analysis of proteoglycan structure, function and metabolism. Curr. Opin. Cell Biol. 3 (1991) 805-816
18. Goldberg I.J. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37 (1996) 693-707
19. Greenwalt D.E., Scheck S.H., and Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 96 (1995) 1382-1388
20. Grosskopf I., Baroukh N., Lee S.J., Kamari Y., Harats D., Rubin E.M., Pennacchio L.A., and Cooper A.D. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2573-2579
21. Hamilton Jr. R.L., Goerke J., Guo L.S.S., Williams M.C., and Havel R.J. Unilamellar liposomes made with the French pressure cell: A simple preparative and semiquantitative technique. J. Lipid Res. 21 (1980) 981-992
22. Havel R.J., and Kane J.P. Introduction: Structure and metabolism of plasma lipoproteins. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 2705-2716
23. Hirano K.-I., Young S.G., Farese Jr. R.V., Ng J., Sande E., Warburton C., Powell-Braxton L.M., and Davidson N.O. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271 (1996) 9887-9890
24. Hocquette J.F., Graulet B., and Olivecrona T. Lipoprotein lipase activity and mRNA levels in bovine tissues. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121 (1998) 201-212
25. Ioka R.X., Kang M.-J., Kamiyama S., Kim D.-H., Magoori K., Kamataki A., Ito Y., Takei Y.A., Sasaki M., Suzuki T., et al. Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1. J. Biol. Chem. 278 (2003) 7344-7349
26. Kingsley D.M., and Krieger M. Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity. Proc. Natl. Acad. Sci. USA 81 (1984) 5454-5458
27. Korn E.D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. Biol. Chem. 215 (1955) 1-14
28. Langner C.A., Birkenmeier E.H., Ben-Zeev O., Schotz M.C., Sweet H.O., Davisson M.T., and Gordon J.I. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J. Biol. Chem. 264 (1989) 7994-8003
29. Lithell H., Boberg J., Hellsing K., Lundqvist G., and Vessby B. Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states. Atherosclerosis 30 (1978) 89-94
30. Lookene A., Beckstead J.A., Nilsson S., Olivecrona G., and Ryan R.O. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J. Biol. Chem. 280 (2005) 25383-25387
31. Low M. Phospholipases that degrade the glycosylphosphatidylinositol anchor of membrane proteins. In: Hooper N., and Turner A. (Eds). Lipid Modifications of Proteins: A Practical Approach (1992), Oxford University Press, Oxford 117-154
32. Lugemwa F.N., and Esko J.D. Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis. J. Biol. Chem. 266 (1991) 6674-6677
33. Mills J.L., Tuomilehto J., Yu K.F., Colman N., Blaner W.S., Koskela P., Rundle W.E., Forman M., Toivanen L., and Rhoads G.G. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediatr. 120 (1992) 863-871
34. Nestel P.J., Havel R.J., and Bezman A. Sites of initial removal of chylomicron triglyceride fatty acids from the blood. J. Clin. Invest. 41 (1962) 1915-1921
35. Nguyen A.T., Braschi S., Geoffrion M., Fong L.G., Crooke R.M., Graham M.J., Young S.G., and Milne R. A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48. Biochim. Biophys. Acta 1761 (2006) 182-185
36. Parthasarathy N., Goldberg I.J., Sivaram P., Mulloy B., Flory D.M., and Wagner W.D. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J. Biol. Chem. 269 (1994) 22391-22396
37. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 31 (2003) e73
38. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.-C., Krauss R.M., and Rubin E.M. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294 (2001) 169-173
39. Redlich C.A., Grauer J.N., Van Bennekum A.M., Clever S.L., Ponn R.B., and Blaner W.S. Characterization of carotenoid, vitamin A, and alpha-tocopheral levels in human lung tissue and pulmonary macrophages. Am. J. Respir. Crit. Care Med. 154 (1996) 1436-1443
40. Sendak R.A., and Bensadoun A. Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis. J. Lipid Res. 39 (1998) 1310-1315
41. Shimada K., Gill P., Silbert J., Douglas W., and Fanburg B. Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J. Clin. Invest. 68 (1981) 995-1002
42. Strauss J.G., Frank S., Kratky D., Hammerle G., Hrzenjak A., Knipping G., von Eckardstein A., Kostner G.M., and Zechner R. Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J. Biol. Chem. 276 (2001) 36083-36090
43. Teng B., and Davidson N.O. Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J. Biol. Chem. 267 (1992) 21265-21272
44. Varma R., and Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394 (1998) 798-801
45. Walzem R.L., Davis P.A., and Hansen R.J. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition. J. Lipid Res. 35 (1994) 1354-1366
46. Weinstock P.H., Bisgaier C.L., Aalto-Setälä K., Radner H., Ramakrishnan R., Levak-Frank S., Essenburg A.D., Zechner R., and Breslow J.L. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96 (1995) 2555-2568